Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide can cause stomach cramps in some people, though the experience varies considerably. Cramping and abdominal discomfort are recognised side effects documented in clinical trial data — they sit within a broader pattern of gastrointestinal effects that are most common during the early weeks of treatment or after a dose increase. These are prescription-only medicines, and a prescriber reviews your full picture before treatment begins. If you're already on Wegovy and wondering whether the cramps you're feeling are typical, read on — this page covers what's known, what usually passes, and when to seek help promptly.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common misreading of early gastrointestinal symptoms is that they signal intolerance or an allergic reaction, and so people stop treatment prematurely. The reality is more straightforward. Semaglutide slows the movement of food through the digestive tract, which is central to how it reduces appetite. That slowing is deliberate. The gut, however, takes time to adjust to this new pace, and cramping is one way it signals the adjustment is under way.
Clinical trial data from the STEP programme (published in the New England Journal of Medicine) showed that gastrointestinal events were the most commonly reported side effects of semaglutide 2.4mg, with the majority occurring early in treatment and described as mild to moderate in severity. Cramping and abdominal pain were part of that picture. They were not a reason the trials excluded participants, they were an expected, managed feature of starting the medicine.
This doesn't mean every cramp should be ignored. It means that transient, manageable discomfort in the first few weeks is part of a well-documented pattern, not a signal that something has gone fundamentally wrong. Our semaglutide overview covers the broader side-effect profile in more detail.
Typical cramping associated with semaglutide tends to be intermittent, located in the mid or lower abdomen, and often accompanies other gut symptoms: nausea, loose stools, constipation, bloating or reflux. It tends to peak in the first one to two weeks after a dose change and then settle. People often notice it more after eating, particularly after larger meals or fatty food, both of which are harder for a slowed stomach to process.
If you've just had your weekly Wegovy injection and you're experiencing cramping in the day or two that follow, that timing is consistent with the known pharmacology. The pattern of cramping after a Wegovy shot is something our prescribers see regularly, it's a question worth raising at your next review, not a reason to stop without speaking to a clinician first.
Cramps that arrive specifically at night, interrupt sleep, or feel different from daytime discomfort are worth noting separately. You can read more about why stomach cramps sometimes worsen overnight on Wegovy, gastric emptying slows further during sleep, and lying flat can make reflux and abdominal pressure more noticeable.
The NHS medicines page for semaglutide lists abdominal pain and discomfort among the common and very common side effects, and advises people to speak to a pharmacist or doctor if symptoms are troublesome.
There is a category of abdominal pain on GLP-1 medicines that is not typical and must not be waited out. In January 2026, the MHRA issued a Drug Safety Update specifically addressing GLP-1 receptor agonists and the risk of acute pancreatitis, a serious but infrequent complication. The signal to act is severe, persistent stomach pain that radiates through to the back, which may or may not be accompanied by vomiting.
That pattern is distinct from ordinary cramping. It doesn't settle with position changes, it doesn't follow the usual post-dose or post-meal rhythm, and it doesn't ease over a day or two. If that description fits what you're experiencing, stop waiting and seek urgent medical help. You can report suspected side effects at any time via the MHRA Yellow Card scheme, which also helps regulators monitor the medicine's safety profile in real-world use.
Gallbladder pain is another possibility with GLP-1 medicines, typically sharp, colicky and felt in the upper right abdomen, sometimes after eating. Again, that's a different character from routine adjustment cramping.
If you're unsure which category your symptoms fall into, contact a healthcare professional. Our aftercare team is available seven days a week for patients treated through nume.
Several practical adjustments are associated with fewer and less intense gastrointestinal symptoms in people taking semaglutide. Eating smaller portions is the single most consistently reported one, the stomach genuinely empties more slowly, so large meals sit longer and cause more discomfort. Rich, fatty or highly processed food is harder to tolerate; leaner, higher-fibre meals tend to be better handled. Eating slowly and stopping when comfortably full, rather than full, matters more on treatment than before it.
Staying well hydrated helps, particularly if cramping is accompanied by loose stools, where fluid loss can compound discomfort. A question our prescribers hear regularly is whether coffee on an empty stomach worsens nausea and cramping; anecdotally, many people find it does, at least in the first weeks.
Understand that dose titration exists precisely to limit this kind of adjustment discomfort. The starting dose of semaglutide is low by design, with increases at roughly four-week intervals, giving the gut time to adapt at each step. If you want to understand more about how semaglutide cramps typically change across the titration schedule, that can help you have a more informed conversation with your prescriber about the pace of titration, rather than stopping the medicine quietly.
For a fuller picture of how dose and side effects interact, our Wegovy information page covers the treatment journey in more detail, and if cramping on Wegovy is your main concern, our guide to Wegovy stomach cramps explains what to expect and when to seek advice. And if you're still weighing whether treatment is right for you, our weight-loss treatment overview sets out the options clearly. When you're ready to speak to a prescriber directly, you can start your free consultation with no obligation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.